238 related articles for article (PubMed ID: 22586492)
1. EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1.
Lau SK; Shields DJ; Murphy EA; Desgrosellier JS; Anand S; Huang M; Kato S; Lim ST; Weis SM; Stupack DG; Schlaepfer DD; Cheresh DA
PLoS One; 2012; 7(5):e36753. PubMed ID: 22586492
[TBL] [Abstract][Full Text] [Related]
2. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis.
Ricono JM; Huang M; Barnes LA; Lau SK; Weis SM; Schlaepfer DD; Hanks SK; Cheresh DA
Cancer Res; 2009 Feb; 69(4):1383-91. PubMed ID: 19208836
[TBL] [Abstract][Full Text] [Related]
3. MUC1 drives c-Met-dependent migration and scattering.
Horm TM; Bitler BG; Broka DM; Louderbough JM; Schroeder JA
Mol Cancer Res; 2012 Dec; 10(12):1544-54. PubMed ID: 23193156
[TBL] [Abstract][Full Text] [Related]
4. Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.
Bernier AJ; Zhang J; Lillehoj E; Shaw AR; Gunasekara N; Hugh JC
Mol Cancer; 2011 Jul; 10():93. PubMed ID: 21798038
[TBL] [Abstract][Full Text] [Related]
5. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.
Roy LD; Sahraei M; Subramani DB; Besmer D; Nath S; Tinder TL; Bajaj E; Shanmugam K; Lee YY; Hwang SI; Gendler SJ; Mukherjee P
Oncogene; 2011 Mar; 30(12):1449-59. PubMed ID: 21102519
[TBL] [Abstract][Full Text] [Related]
6. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
[TBL] [Abstract][Full Text] [Related]
7. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.
Desgrosellier JS; Barnes LA; Shields DJ; Huang M; Lau SK; Prévost N; Tarin D; Shattil SJ; Cheresh DA
Nat Med; 2009 Oct; 15(10):1163-9. PubMed ID: 19734908
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.
Demory ML; Boerner JL; Davidson R; Faust W; Miyake T; Lee I; Hüttemann M; Douglas R; Haddad G; Parsons SJ
J Biol Chem; 2009 Dec; 284(52):36592-36604. PubMed ID: 19840943
[TBL] [Abstract][Full Text] [Related]
9. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.
Bitler BG; Goverdhan A; Schroeder JA
J Cell Sci; 2010 May; 123(Pt 10):1716-23. PubMed ID: 20406885
[TBL] [Abstract][Full Text] [Related]
10. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.
Li Y; Ren J; Yu W; Li Q; Kuwahara H; Yin L; Carraway KL; Kufe D
J Biol Chem; 2001 Sep; 276(38):35239-42. PubMed ID: 11483589
[TBL] [Abstract][Full Text] [Related]
11. EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation.
Chen Y; Long H; Wu Z; Jiang X; Ma L
Mol Biol Cell; 2008 Jul; 19(7):2973-83. PubMed ID: 18463167
[TBL] [Abstract][Full Text] [Related]
12. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin.
Li Y; Kuwahara H; Ren J; Wen G; Kufe D
J Biol Chem; 2001 Mar; 276(9):6061-4. PubMed ID: 11152665
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
14. MUC1 stimulates EGFR expression and function in endometrial cancer.
Engel BJ; Bowser JL; Broaddus RR; Carson DD
Oncotarget; 2016 May; 7(22):32796-809. PubMed ID: 27092881
[TBL] [Abstract][Full Text] [Related]
15. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
17. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
18. Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines.
Neeraja Dharmaraj ; Engel BJ; Carson DD
J Cell Biochem; 2013 Oct; 114(10):2314-22. PubMed ID: 23686469
[TBL] [Abstract][Full Text] [Related]
19. Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src.
Jaganathan S; Yue P; Turkson J
J Pharmacol Exp Ther; 2010 May; 333(2):373-81. PubMed ID: 20100905
[TBL] [Abstract][Full Text] [Related]
20. NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling.
Lillehoj EP; Hyun SW; Feng C; Zhang L; Liu A; Guang W; Nguyen C; Luzina IG; Atamas SP; Passaniti A; Twaddell WS; Puché AC; Wang LX; Cross AS; Goldblum SE
J Biol Chem; 2012 Mar; 287(11):8214-31. PubMed ID: 22247545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
